PEAK6 Investments’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,400
Closed -$167K 3550
2024
Q1
$167K Buy
+8,400
New +$162K ﹤0.01% 3156
2020
Q4
Sell
-29,000
Closed -$963K 4544
2020
Q3
$963K Hold
29,000
﹤0.01% 2300
2020
Q2
$852K Sell
29,000
-6,900
-19% -$200K ﹤0.01% 2234
2020
Q1
$967K Buy
+35,900
New +$1.07M 0.01% 1560
2019
Q4
Sell
-7,300
Closed -$273K 3375
2019
Q3
$273K Buy
+7,300
New +$278K ﹤0.01% 2703
2019
Q2
Sell
-13,700
Closed -$585K 3653
2019
Q1
$585K Buy
13,700
+7,400
+117% +$331K ﹤0.01% 2266
2018
Q4
$282K Buy
+6,300
New +$330K ﹤0.01% 2779

Other funds holding AVNS

PEAK6 Investments's AVNS Position: Q2 2024 in Review

PEAK6 Investments sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 2,969 shares — an estimated $59.1K sold.

PEAK6 Investments first reported a position in AVNS in Q4 2018 and held it in 4 quarters. The position peaked at $456K in Q4 2021. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • PEAK6 Investments reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,969 Avanos Medical shares in Q2 2024, an estimated $59.1K.
  • PEAK6 Investments first reported a position in Avanos Medical in Q4 2018 and held it in 4 quarters.
  • PEAK6 Investments's Avanos Medical position peaked at $456K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.